The University of Southampton
University of Southampton Institutional Repository

Association between single dose and longer-term clinical response to stimulants in ADHD: a systematic review of randomized controlled trials.: Single dose and long-term ADHD treatment response

Association between single dose and longer-term clinical response to stimulants in ADHD: a systematic review of randomized controlled trials.: Single dose and long-term ADHD treatment response
Association between single dose and longer-term clinical response to stimulants in ADHD: a systematic review of randomized controlled trials.: Single dose and long-term ADHD treatment response
Objectives: stimulants, such as methylphenidate (MPH) and amphetamines, represent the first-line pharmacological option for Attention-deficit/hyperactivity disorder (ADHD). Randomized controlled trials (RCTs) have demonstrated beneficial effects at a group level but could not identify characteristics consistently associated with varying individual response. Thus, more individualized approaches are needed. Experimental studies have suggested that the neurobiological response to a single dose is indicative of longer-term response. It is unclear whether this also applies to clinical measures.

Methods: we carried out a systematic review of RCTs testing the association between the clinical response to a single dose of stimulants and longer-term improvement. Potentially suitable single-dose RCTs were identified from the MED-ADHD dataset, the European ADHD Guidelines Group (EAGG) RCT Dataset (https://med-adhd.org/), as updated on the 01/02/2024. Quality assessment was carried out using the Cochrane Risk of Bias (RoB) 2.0 tool.

Results: 63 single-dose RCTs (94% testing MPH, 85% in children) were identified. Among these, only one RCT tested the association between acute and longer-term clinical response. This showed that the clinical improvement after a single dose of MPH was significantly associated with symptom improvement after four-week MPH treatment in 46 children (89% males) with ADHD. The risk of bias was rated as moderate. A further RCT used near-infrared spectroscopy (NIRS), thus did not meet inclusion criteria, and reported an association between brain changes under a single dose and longer-term clinical response in 22 children (82% males) with ADHD. The remaining RCTs only reported single dose effects on neuropsychological, neuroimaging or neurophysiological measures.

Conclusion: this systematic review highlighted an important gap in the current knowledge. Investigating how acute and long-term response may be related can foster our understanding of stimulant mechanism of action and help develop stratification approaches for more tailored treatment strategies. Future studies need to investigate potential age and sex-related differences.
Attention-deficit/hyperactivity disorder (ADHD); stimulant; methylphenidate (MPH); single dose; treatment response; randomized controlled trials (RCTs).
1044-5463
Parlatini, Valeria
6cdfb200-40ce-43ce-84da-dcb6eba0f67a
Bellato, Alessio
0ee4c34f-3850-4883-8b82-5717b74990f7
Roy, Sulagna
e19ccb41-6850-40b7-8da4-7952b1c8cf2d
Murphy, Declan
e9bd7d40-a8fd-4732-abfe-f8a9dae34a7f
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Parlatini, Valeria
6cdfb200-40ce-43ce-84da-dcb6eba0f67a
Bellato, Alessio
0ee4c34f-3850-4883-8b82-5717b74990f7
Roy, Sulagna
e19ccb41-6850-40b7-8da4-7952b1c8cf2d
Murphy, Declan
e9bd7d40-a8fd-4732-abfe-f8a9dae34a7f
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb

Parlatini, Valeria, Bellato, Alessio, Roy, Sulagna, Murphy, Declan and Cortese, Samuele (2024) Association between single dose and longer-term clinical response to stimulants in ADHD: a systematic review of randomized controlled trials.: Single dose and long-term ADHD treatment response. Journal of Child and Adolescent Psychopharmacology.

Record type: Article

Abstract

Objectives: stimulants, such as methylphenidate (MPH) and amphetamines, represent the first-line pharmacological option for Attention-deficit/hyperactivity disorder (ADHD). Randomized controlled trials (RCTs) have demonstrated beneficial effects at a group level but could not identify characteristics consistently associated with varying individual response. Thus, more individualized approaches are needed. Experimental studies have suggested that the neurobiological response to a single dose is indicative of longer-term response. It is unclear whether this also applies to clinical measures.

Methods: we carried out a systematic review of RCTs testing the association between the clinical response to a single dose of stimulants and longer-term improvement. Potentially suitable single-dose RCTs were identified from the MED-ADHD dataset, the European ADHD Guidelines Group (EAGG) RCT Dataset (https://med-adhd.org/), as updated on the 01/02/2024. Quality assessment was carried out using the Cochrane Risk of Bias (RoB) 2.0 tool.

Results: 63 single-dose RCTs (94% testing MPH, 85% in children) were identified. Among these, only one RCT tested the association between acute and longer-term clinical response. This showed that the clinical improvement after a single dose of MPH was significantly associated with symptom improvement after four-week MPH treatment in 46 children (89% males) with ADHD. The risk of bias was rated as moderate. A further RCT used near-infrared spectroscopy (NIRS), thus did not meet inclusion criteria, and reported an association between brain changes under a single dose and longer-term clinical response in 22 children (82% males) with ADHD. The remaining RCTs only reported single dose effects on neuropsychological, neuroimaging or neurophysiological measures.

Conclusion: this systematic review highlighted an important gap in the current knowledge. Investigating how acute and long-term response may be related can foster our understanding of stimulant mechanism of action and help develop stratification approaches for more tailored treatment strategies. Future studies need to investigate potential age and sex-related differences.

Text
Main manuscript_dm_v_SC_v_SC_vv_revised_cleaned - Accepted Manuscript
Download (53kB)

More information

Published date: 20 June 2024
Keywords: Attention-deficit/hyperactivity disorder (ADHD); stimulant; methylphenidate (MPH); single dose; treatment response; randomized controlled trials (RCTs).

Identifiers

Local EPrints ID: 492752
URI: http://eprints.soton.ac.uk/id/eprint/492752
ISSN: 1044-5463
PURE UUID: 57953707-57d0-4202-9161-3149cac652bd
ORCID for Valeria Parlatini: ORCID iD orcid.org/0000-0002-4754-2494
ORCID for Alessio Bellato: ORCID iD orcid.org/0000-0001-5330-6773
ORCID for Sulagna Roy: ORCID iD orcid.org/0009-0005-6824-7266
ORCID for Samuele Cortese: ORCID iD orcid.org/0000-0001-5877-8075

Catalogue record

Date deposited: 13 Aug 2024 16:54
Last modified: 10 Sep 2024 02:09

Export record

Contributors

Author: Valeria Parlatini ORCID iD
Author: Alessio Bellato ORCID iD
Author: Sulagna Roy ORCID iD
Author: Declan Murphy
Author: Samuele Cortese ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×